Head-to-Head

Caris Life Sciences, Inc. Common Stock vs. Veracyte, Inc.

CAI

Caris Life Sciences, Inc. Common Stock

$18.54 -4.92%

VS VCYT

Veracyte, Inc.

$25.13 +0.36%

Caris Life Sciences, Inc. Common Stock (CAI) comes out ahead, leading on 2 of 2 compared factors.

Size & Scale

CAIVCYT
Market Cap $5.59 billion $2.03 billion

CAI leads on 1 of 1 size & scale factors.

Dividend

CAIVCYT
Dividend Yield 6.47% —

CAI and VCYT split the dividend factors evenly.

Risk & Sentiment

CAIVCYT
Short Interest 0.13% 0.83%

CAI leads on 1 of 1 risk & sentiment factors.

Dig deeper: CAI overview, CAI financials, VCYT overview, VCYT financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.